What is Ortec?
Ortec Inc. operates as a custom chemical manufacturing and research firm, dedicated to empowering clients to achieve their market objectives through specialized technical expertise and tailored service offerings. The company's portfolio includes performance polymers and specialty chemicals, serving a broad spectrum of industries such as coatings, adhesives, and life sciences. With a strong emphasis on quality systems and adherence to regulatory compliance, Ortec provides cGMP manufacturing capabilities for FDA-regulated markets, including pharmaceuticals and medical devices. Their commitment to operational efficiency and client confidentiality positions them as a reliable partner for businesses aiming to scale production from laboratory research to full commercialization.
How much funding has Ortec raised?
Ortec has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Ortec
PPP
Public-Private Partnership
What's next for Ortec?
The recent major strategic investment in Ortec signals a pivotal phase for the company, likely enabling accelerated expansion of its manufacturing capabilities, research and development initiatives, and market penetration. This capital infusion is expected to bolster Ortec's capacity to serve demanding sectors like pharmaceuticals and medical devices, particularly within cGMP-compliant environments. The company's focus on technical expertise and personalized service, combined with this significant financial backing, positions Ortec to further solidify its role as a key partner for clients navigating complex product development and commercialization pathways.
See full Ortec company page
